Keymed Biosciences Co.ltd

This study tests a new drug called CM313, given as an injection under the skin, for people with a kidney disease called IgA nephropathy. The goal is to see if it is safe and helps control the disease. About 106 adults with confirmed IgA nephropathy and moderate kidney function wi…

This study compares a new drug called CM336 to the usual treatments for people with multiple myeloma that has come back or stopped responding after at least two prior therapies. About 280 adults will be randomly assigned to receive either CM336 or a standard treatment chosen by t…

This study tests the safety and effectiveness of a drug called CM512 in 120 people with chronic sinusitis and nasal polyps. Participants must have been in a previous CM512 study. The goal is to see if CM512 can help control the disease, but ongoing treatment may be needed.